Herwig‐Ulf Meier‐Kriesche

9.2k total citations · 3 hit papers
62 papers, 7.0k citations indexed

About

Herwig‐Ulf Meier‐Kriesche is a scholar working on Transplantation, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Herwig‐Ulf Meier‐Kriesche has authored 62 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Transplantation, 29 papers in Surgery and 27 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Herwig‐Ulf Meier‐Kriesche's work include Renal Transplantation Outcomes and Treatments (50 papers), Organ Transplantation Techniques and Outcomes (28 papers) and Organ Donation and Transplantation (24 papers). Herwig‐Ulf Meier‐Kriesche is often cited by papers focused on Renal Transplantation Outcomes and Treatments (50 papers), Organ Transplantation Techniques and Outcomes (28 papers) and Organ Donation and Transplantation (24 papers). Herwig‐Ulf Meier‐Kriesche collaborates with scholars based in United States, Sweden and Belgium. Herwig‐Ulf Meier‐Kriesche's co-authors include Bruce Kaplan, Jesse D. Schold, Titte R. Srinivas, Julie Arndorfer, Rajendra Baliga, Diane M. Cibrik, Akinlolu Ojo, Alan Reed, Julie A. Hanson and Alan B. Leichtman and has published in prestigious journals such as Diabetes Care, Journal of the American Society of Nephrology and Journal of the American Geriatrics Society.

In The Last Decade

Herwig‐Ulf Meier‐Kriesche

61 papers receiving 6.9k citations

Hit Papers

Lack of Improvement in Renal Allograft Survival Despite a... 2002 2026 2010 2018 2004 2002 2004 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era
    2004 1.0k citations Herwig‐Ulf Meier‐Kriesche, Jesse D. Schold et al. American Journal of Transplantation profile →
  2. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes
    2002 559 citations Herwig‐Ulf Meier‐Kriesche, Bruce Kaplan Transplantation profile →
  3. Long-Term Renal Allograft Survival: Have we Made Significant Progress or is it Time to Rethink our Analytic and Therapeutic Strategies?
    2004 466 citations Herwig‐Ulf Meier‐Kriesche, Jesse D. Schold et al. American Journal of Transplantation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Herwig‐Ulf Meier‐Kriesche United States 42 5.1k 3.3k 2.2k 1.2k 992 62 7.0k
Kristen J. Gillingham United States 48 4.8k 0.9× 3.6k 1.1× 2.6k 1.2× 1.4k 1.2× 714 0.7× 155 7.1k
Stuart M. Flechner United States 43 3.5k 0.7× 2.8k 0.9× 1.6k 0.7× 1.2k 1.0× 559 0.6× 195 6.1k
Sundaram Hariharan United States 44 4.7k 0.9× 2.9k 0.9× 1.7k 0.8× 1.2k 1.0× 1.0k 1.0× 164 7.4k
Herwig‐Ulf Meier‐Kriesche United States 35 3.8k 0.8× 2.3k 0.7× 1.5k 0.7× 687 0.6× 653 0.7× 73 5.7k
David N. Rush Canada 47 6.4k 1.3× 4.1k 1.3× 1.4k 0.6× 1.1k 0.9× 2.1k 2.1× 145 8.8k
Suphamai Bunnapradist United States 51 3.9k 0.8× 2.8k 0.9× 1.4k 0.6× 693 0.6× 1.1k 1.1× 208 6.9k
Karsten Midtvedt Norway 41 3.0k 0.6× 1.9k 0.6× 1.3k 0.6× 1.0k 0.8× 697 0.7× 196 5.2k
Robert A. Montgomery United States 62 6.0k 1.2× 5.0k 1.5× 4.1k 1.8× 2.1k 1.7× 1.6k 1.7× 202 10.5k
Oscar Salvatierra United States 44 3.4k 0.7× 2.6k 0.8× 1.6k 0.7× 1.2k 1.0× 948 1.0× 195 6.3k
Ronald M. Ferguson United States 47 3.1k 0.6× 2.4k 0.7× 933 0.4× 701 0.6× 533 0.5× 149 6.0k

Countries citing papers authored by Herwig‐Ulf Meier‐Kriesche

Since Specialization
Citations

This map shows the geographic impact of Herwig‐Ulf Meier‐Kriesche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herwig‐Ulf Meier‐Kriesche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herwig‐Ulf Meier‐Kriesche more than expected).

Fields of papers citing papers by Herwig‐Ulf Meier‐Kriesche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herwig‐Ulf Meier‐Kriesche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herwig‐Ulf Meier‐Kriesche. The network helps show where Herwig‐Ulf Meier‐Kriesche may publish in the future.

Co-authorship network of co-authors of Herwig‐Ulf Meier‐Kriesche

This figure shows the co-authorship network connecting the top 25 collaborators of Herwig‐Ulf Meier‐Kriesche. A scholar is included among the top collaborators of Herwig‐Ulf Meier‐Kriesche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herwig‐Ulf Meier‐Kriesche. Herwig‐Ulf Meier‐Kriesche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schold, Jesse D., Jon A. Gregg, Jeffrey S. Harman, et al.. (2011). Barriers to Evaluation and Wait Listing for Kidney Transplantation. Clinical Journal of the American Society of Nephrology. 6(7). 1760–1767. 153 indexed citations
2.
Meier‐Kriesche, Herwig‐Ulf, et al.. (2007). Immunosuppressive Strategies to Improve Outcomes of Kidney Transplantation. Seminars in Nephrology. 27(4). 377–392. 17 indexed citations
3.
Schold, Jesse D., Herwig‐Ulf Meier‐Kriesche, R. Paul Duncan, & Alan Reed. (2007). Deceased Donor Kidney and Liver Transplantation to Nonresident Aliens in the United States. Transplantation. 84(12). 1548–1556. 12 indexed citations
4.
Schold, Jesse D. & Herwig‐Ulf Meier‐Kriesche. (2006). Which Renal Transplant Candidates Should Accept Marginal Kidneys in Exchange for a Shorter Waiting Time on Dialysis?. Clinical Journal of the American Society of Nephrology. 1(3). 532–538. 140 indexed citations
5.
Schold, Jesse D., Bruce Kaplan, Richard J. Howard, et al.. (2005). Are We Frozen in Time? Analysis of the Utilization and Efficacy of Pulsatile Perfusion in Renal Transplantation. American Journal of Transplantation. 5(7). 1681–1688. 116 indexed citations
6.
Schold, Jesse D., Bruce Kaplan, Neale R. Chumbler, et al.. (2005). Access to Quality. Journal of the American Society of Nephrology. 16(10). 3121–3127. 37 indexed citations
7.
Meier‐Kriesche, Herwig‐Ulf, Jesse D. Schold, Titte R. Srinivas, Alan Reed, & Bruce Kaplan. (2004). Kidney Transplantation Halts Cardiovascular Disease Progression in Patients with End-Stage Renal Diseas. American Journal of Transplantation. 4(10). 1662–1668. 246 indexed citations
8.
Meier‐Kriesche, Herwig‐Ulf, Bettina J. Steffen, Alice Chu, et al.. (2004). Sirolimus with Neoral Versus Mycophenolate Mofetil with Neoral is Associated with Decreased Renal Allograft Survival. American Journal of Transplantation. 4(12). 2058–2066. 55 indexed citations
9.
Meier‐Kriesche, Herwig‐Ulf, Jesse D. Schold, & Bruce Kaplan. (2004). Long-Term Renal Allograft Survival: Have we Made Significant Progress or is it Time to Rethink our Analytic and Therapeutic Strategies?. American Journal of Transplantation. 4(8). 1289–1295. 466 indexed citations breakdown →
10.
Kaplan, Bruce, Jesse D. Schold, & Herwig‐Ulf Meier‐Kriesche. (2003). Long-Term Graft Survival with Neoral and Tacrolimus. Journal of the American Society of Nephrology. 14(11). 2980–2984. 90 indexed citations
11.
Meier‐Kriesche, Herwig‐Ulf & Bruce Kaplan. (2002). Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes. Transplantation. 74(10). 1377–1381. 559 indexed citations breakdown →
12.
Cibrik, Diane M., Bruce Kaplan, Julie Arndorfer, & Herwig‐Ulf Meier‐Kriesche. (2002). Renal allograft survival in patients with oxalosis1. Transplantation. 74(5). 707–710. 52 indexed citations
13.
Kaplan, Bruce & Herwig‐Ulf Meier‐Kriesche. (2002). Death After Graft Loss: An Important Late Study Endpoint in Kidney Transplantation. American Journal of Transplantation. 2(10). 970–974. 215 indexed citations
14.
Rudich, Steven M., Bruce Kaplan, John C. Magee, et al.. (2002). Renal transplantations performed using non???heart-beating organ donors: going back to the future?1. Transplantation. 74(12). 1715–1720. 97 indexed citations
15.
Meier‐Kriesche, Herwig‐Ulf & Bruce Kaplan. (2001). Immunosuppression in Elderly Renal Transplant Recipients. Drugs & Aging. 18(10). 751–759. 37 indexed citations
16.
Meier‐Kriesche, Herwig‐Ulf, Akinlolu Ojo, Julie A. Hanson, et al.. (2000). INCREASED IMMUNOSUPPRESSIVE VULNERABILITY IN ELDERLY RENAL TRANSPLANT RECIPIENTS1,2. Transplantation. 69(5). 885–889. 130 indexed citations
17.
Meier‐Kriesche, Herwig‐Ulf, Melvin Bonilla‐Félix, María Ferris, et al.. (1999). A limited sampling strategy for the estimation of Neoral AUCs in pediatric patients. Pediatric Nephrology. 13(9). 742–747. 21 indexed citations
18.
Craig, Robert M., Michaël Abécassis, Dixon B. Kaufman, et al.. (1999). LOW BIOAVAILABILITY OF CYCLOSPORINE MICROEMULSION AND TACROLIMUS IN A SMALL BOWEL TRANSPLANT RECIPIENT. Transplantation. 67(2). 333–335. 53 indexed citations
19.
Meier‐Kriesche, Herwig‐Ulf, et al.. (1999). INFECTIOUS COMPLICATIONS IN GERIATRIC RENAL TRANSPLANT PATIENTS. Transplantation. 68(10). 1496–1502. 74 indexed citations
20.
Kaplan, Bruce, Herwig‐Ulf Meier‐Kriesche, Kimberly L. Napoli, & Barry D. Kahan. (1998). The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent*. Clinical Pharmacology & Therapeutics. 63(1). 48–53. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristen J. Gillingham Breakdown of academic impact, for papers by Stuart M. Flechner Breakdown of academic impact, for papers by Sundaram Hariharan Breakdown of academic impact, for papers by Herwig‐Ulf Meier‐Kriesche Breakdown of academic impact, for papers by David N. Rush Breakdown of academic impact, for papers by Suphamai Bunnapradist Breakdown of academic impact, for papers by Karsten Midtvedt Breakdown of academic impact, for papers by Robert A. Montgomery Breakdown of academic impact, for papers by Oscar Salvatierra Breakdown of academic impact, for papers by Ronald M. Ferguson
Rankless by CCL
2026